These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2058763)

  • 21. Some limitations on studies about the relation between gross cystic disease and risk of subsequent breast cancer.
    Bodian CA
    Ann N Y Acad Sci; 1990; 586():259-65. PubMed ID: 2357006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspiration cytology of breast cysts.
    Takeda T; Suzuki M; Sato Y; Hase T; Yamada S
    Acta Cytol; 1982; 26(1):37-8. PubMed ID: 6950625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.
    Washington C; Dalbègue F; Abreo F; Taubenberger JK; Lichy JH
    Am J Pathol; 2000 Jul; 157(1):323-9. PubMed ID: 10880402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?
    Bundred NJ; West RR; Dowd JO; Mansel RE; Hughes LE
    Br J Cancer; 1991 Nov; 64(5):953-5. PubMed ID: 1931623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early apocrine change in hyperplastic cystic disease.
    Vilanova JR; Simon R; Alvarez J; Rivera-Pomar JM
    Histopathology; 1983 Sep; 7(5):693-8. PubMed ID: 6195070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts.
    Wellings SR; Alpers CE
    Hum Pathol; 1987 Apr; 18(4):381-6. PubMed ID: 3557440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
    Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
    APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extra-tumoral breast tissue in breast-cancer patients: variations with a family history of breast cancer. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1998 Feb; 79(1):39-43. PubMed ID: 9495356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystic fibroadenoma: report of a rare case with review of literature.
    Bhat A; Vijaya C; Gowda VS
    Breast Dis; 2015; 35(1):49-52. PubMed ID: 25095984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Giant cystic metaplastic carcinoma of the breast: a case report with diagnosis by fine needle aspiration.
    Kumar PV; Monabati A; Talei AR; Boub R
    Acta Cytol; 2006; 50(3):327-30. PubMed ID: 16780030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gross cystic disease of the breast.
    Greenblatt RB; Mahesh VB; Sullivan D
    Maturitas; 1987 Aug; 9(2):171-81. PubMed ID: 3657597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for fibrocystic breast disease and its histopathologic components.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; White C
    J Natl Cancer Inst; 1985 Jul; 75(1):43-50. PubMed ID: 3859695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.
    diFlorio-Alexander RM; Marotti JD; Bond JS; Schwab MC; Memoli VA; Wells WA; Poplack SP
    AJR Am J Roentgenol; 2015 Jan; 204(1):211-8. PubMed ID: 25539259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uneven distribution and significant concentration of apocrine metaplasia in lower breast quadrants.
    Benigni G; Squartini F
    Tumori; 1986 Apr; 72(2):179-82. PubMed ID: 3705191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast.
    Tavassoli FA; Norris HJ
    Cancer; 1990 Feb; 65(3):518-29. PubMed ID: 2297643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K; Zych F
    Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipids status in human breast cyst fluids.
    Mannello F; Bocchiotti GD; Morano FP; Fratepietro LM; Gazzanelli G
    Cancer Lett; 1996 Jan; 98(2):137-43. PubMed ID: 8556700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.